Shandong Weigao Group Medical Polymer Company Limited
SHWGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $6,644 | $6,451 | $6,636 | $6,332 |
| % Growth | 3% | -2.8% | 4.8% | – |
| Cost of Goods Sold | $3,341 | $3,292 | $3,259 | $3,264 |
| Gross Profit | $3,304 | $3,159 | $3,376 | $3,067 |
| % Margin | 49.7% | 49% | 50.9% | 48.4% |
| R&D Expenses | $316 | $470 | $302 | $437 |
| G&A Expenses | $620 | $754 | $540 | $712 |
| SG&A Expenses | $1,812 | $1,825 | $1,812 | $1,966 |
| Sales & Mktg Exp. | $1,180 | $1,071 | $1,265 | $1,261 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,128 | $2,295 | $2,113 | $2,337 |
| Operating Income | $1,176 | $864 | $1,263 | $919 |
| % Margin | 17.7% | 13.4% | 19% | 14.5% |
| Other Income/Exp. Net | $50 | $323 | $103 | -$18 |
| Pre-Tax Income | $1,226 | $1,187 | $1,366 | $901 |
| Tax Expense | $169 | $178 | $213 | $82 |
| Net Income | $1,008 | $959 | $1,108 | $804 |
| % Margin | 15.2% | 14.9% | 16.7% | 12.7% |
| EPS | 0.22 | 0.2 | 0.24 | 0.175 |
| % Growth | 10% | -16.7% | 37.5% | – |
| EPS Diluted | 0.22 | 0.2 | 0.24 | 0.178 |
| Weighted Avg Shares Out | 4,583 | 4,666 | 4,615 | 4,608 |
| Weighted Avg Shares Out Dil | 4,543 | 4,569 | 4,615 | 4,530 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $112 | $0 | $104 |
| Interest Expense | $117 | $0 | $129 | $0 |
| Depreciation & Amortization | $463 | $487 | $435 | $581 |
| EBITDA | $1,638 | $1,498 | $1,698 | $1,384 |
| % Margin | 24.7% | 23.2% | 25.6% | 21.9% |